| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 28, 2026 | ±2.8% | +12.6% | under-priced |
| February 26, 2026 | ±2.4% | -1.9% | over-priced |
| August 28, 2025 | ±1.5% | -13.1% | under-priced |
| May 29, 2025 | ±2.2% | +1.1% | over-priced |
| February 27, 2025 | ±2.4% | -1.2% | over-priced |
| September 4, 2024 | ±1.7% | -6.4% | under-priced |
| February 29, 2024 | ±2.2% | +14.6% | under-priced |
| August 31, 2023 | ±1.4% | -2.7% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.29 | $3.0B | $157M |
| Q1 FY2026 | $0.33 | $3.0B | $182M |
| Q4 FY2025 | $-0.10 | $3.2B | $-56M |
| Q3 FY2025 | $0.33 | $3.0B | $184M |
Hormel Foods Corporation (HRL) reports in 97 days, with the next report estimated for September 18, 2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 6.7% on average — the market has been roughly fair on HRL's earnings risk. Fundamentals into the print: EPS down 12.1% year-over-year, revenue up 2.5%. QuantLogix's live 5-factor engine currently reads HRL as a buy at 59/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →